A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...

A new research paper was published in Oncotarget's Volume 16 on January 20, 2025, titled "Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells." ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase ...

Metastatic Breast Cancer MBC is an advanced form of breast cancer that can spread from the breast to other parts of the body making treatment more complex Heres how advanced treatment can help transfo ...

A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...

R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

The Arkansas Integrative Metabolic Research Center will host Jeffrey Rathmell, a professor of pathology, microbiology and immunology from Vanderbilt University on Wednesday, Jan. 22.

Inductees Vivian Campbell, from left, Joe Elliott and Phil Collen, of Def Leppard, perform at the Rock & Roll Hall of Fame ...